Do nurses have the switch factor?

Mulders, Greta; Uitslager, Nanda; Alavian, Sharon; Wareing, Anne; Stein Oldenburg, Kathi

doi:10.17225/jhp00162

References

Franchini M, Mannucci PM. The history of hemophilia. Semin Thromb Hemost 2014; 40(5): 571–76. doi: 10.1055/s-0034-1381232.
Open DOI Search in Google Scholar Back to article
Mannucci PM. Miracle of haemophilia drugs: personal views about a few main players. Haemophilia 2018; 24(4): 557–62. doi: 10.1111/hae.13519.
Open DOI Search in Google Scholar Back to article
Giangrande PLF, Peyvandi F, O'Mahony B, et al. Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentrates. Haemophilia 2017; 23(3): 370–75. doi: 10.1111/hae.13211.
Open DOI Search in Google Scholar Back to article
Collins PW, Chalmers E, Hart DP, et al. Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition). UK Haemophilia Centre Doctors Organization. Br J Haematol 2013; 160(2): 153–70. doi: 10.1111/bjh.12091.
Open DOI Search in Google Scholar Back to article
Carcao M. Switching from current factor VIII (FVIII) to longer acting FVIII concentrates – what is the real potential benefit? Haemophilia 2015; 21(3): 297–9. doi: 10.1111/hae.12671.
Open DOI Search in Google Scholar Back to article
Croteau SE, Neufeld EJ. Transition considerations for extended half-life factor products. Haemophilia 2015; 21(3): 285–8. doi: 10.1111/hae.12683.
Open DOI Search in Google Scholar Back to article
Collins P, Chalmers E, Chowdary P, et al. The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO. Haemophilia 2016; 22(4): 487–98. doi: 10.1111/hae.13013.
Open DOI Search in Google Scholar Back to article
Pollard D, Khair K, Holland M. Switching factor products: nurses’ experience with NovoEight. J Haem Pract 2020; 7(1): 59–69. doi: 10.17225/jhp00156.
Open DOI Search in Google Scholar Back to article
Santagostino E, Auerswald G, Benson G, et al. Switching treatments in haemophilia: is there a risk of inhibitor development? Eur J Haematol 2015; 94(4): 284–89. doi: 10.1111/ejh.12433.
Open DOI Search in Google Scholar Back to article
Hay CR, Palmer BP, Chalmers EA, et al. The incidence of factor VIII inhibitors in severe haemophilia A following a major switch from full-length to B-domain-deleted factor VIII: a prospective cohort comparison. Haemophilia 2015; 21(2): 219–26. doi: 10.1111/hae.12563.
Open DOI Search in Google Scholar Back to article
Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia 2020 Aug 3. doi: 10.1111/hae.14046. Epub ahead of print.
Open DOI Search in Google Scholar Back to article
Pollard D, Khair K, Holland M. Experience of switching to NovoEight: views of people with haemophilia. J Haem Pract 2020; 7(1): 70–77. doi: 10.17225/jhp00157.
Open DOI Search in Google Scholar Back to article
Shay LA, Lafata JE. Where is the evidence? A systematic review of shared decision making and patient outcomes. Med Decis Making 2015; 35(1): 114–31. doi: 10.1177/0272989x14551638.
Open DOI Search in Google Scholar Back to article
Mantovani LG, Monzini MS, Mannucci PM, et al; Conan Study Group. Differences between patients’, physicians’ and pharmacists’ preferences for treatment products in haemophilia: a discrete choice experiment. Haemophilia 2005; 11(6): 589–97. doi: 10.1111/j.1365-2516.2005.01159.x.
Open DOI Search in Google Scholar Back to article
von Mackensen S, Kalnins W, Krucker J, et al. Haemophilia patients’ unmet needs and their expectations of the new extended half-life factor concentrates. Haemophilia 2017; 23(4): 566–74. doi: 10.1111/hae.13221.
Open DOI Search in Google Scholar Back to article
Khair K, Pollard D, Harrison C, Hook S, O'Driscoll M, Holland M. HOw Patients view Extended half-life products: impressions from real-world experience (The HOPE study). Haemophilia 2019; 25(5): 814–20. doi: 10.1111/hae.13803.
Open DOI Search in Google Scholar Back to article
Smit C. Personal reflections of a patient representative in an appraisal committee. Patient 2015; 8(1): 5–10. doi: 10.1007/s40271-014-0086-8.
Open DOI Search in Google Scholar Back to article

Do nurses have the switch factor?

References

Paradigm

My account